Collaboration - December 22, 2021
Season’s Greetings from Nordic Life Science
We would like to thank our readers, subscribers and collaboration partners for a fruitful 2021, and we wish you all a most wonderful holiday season! 2021 has been – yet another – challenging year and we have reported about both global and Nordic efforts to handle, treat and prevent COVID-19. But we have also seen […]
Collaboration - December 22, 2021
Gedea receives funding for microbiome research project
Gedea Biotech has received funding for a research project with the Centre for Translational Microbiome Research at Karolinska Institutet (KI), for its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV). The project goal is to better understand the microbial etiology of bacterial vaginosis (BV) and factors associated with successful, antibiotic-free […]
Collaboration - November 30, 2021
Immunicum and PCI Biotech extend their collaboration
Immunicum and PCI Biotech Holding have announced an extension of their current research collaboration to explore novel cancer vaccination treatments. The companies jointly research the possibility to overcome current hurdles in cancer immunotherapy by introducing tumor independent immune targets into the tumor microenvironment, in combination with vaccination or adoptive immunotherapies. The so-called Tumor Independent Antigen […]
Collaboration - November 26, 2021
Six Swedish start-ups selected to accelerate in the French market
In July EIT Health launched a new joint accelerator programme for Swedish start-ups in digital health and artificial intelligence (AI) with support from the Swedish Innovation Agency Vinnova within the framework of the strategic innovation partnership between Sweden and France. During 12 months six selected Swedish start-ups specialized in digital health and in artificial intelligence […]
Collaboration - November 18, 2021
#WAAW: New group of antibacterial molecules identified
Researchers at Karolinska Institutet, Umeå University, and the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic-resistant bacteria. Since the properties of the molecules can easily be altered chemically, the hope is to develop new, effective antibiotics with few side effects. The findings have been published […]
Business article - November 9, 2021
New report: The state of Medicon Valley
The new “State of Medicon Valley analysis – An analysis of life science in Greater Copenhagen”, includes a close examination of the development of the cluster’s regional beacons. Medicon Valley Alliance (MVA)’s new CEO, Anette Steenberg presented the highlights from the report at MVA’s Annual Meeting, November 8th, at Clarion Hotel Copenhagen Airport. In the […]
